Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SK-1405 Receptor Occupancy in Healthy Caucasian Males
NCT02650076Phase 1Completed
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Jan 2016
- Primary completion
- Apr 2016
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of SK-1405 in pruritus, sponsored by Sanwa Kagaku Kenkyusho Co., Ltd. Primary endpoint: Receptor occupancy of SK-1405 at 4 days. Started Jan 2016; status: completed.
02
Drugs
SK-1405
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT02650076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02650076.